Roots Analysis and the New Era of AI-Enabled Market Intelligence
The challenge facing pharmaceutical and biotech intelligence teams is no longer simply finding information. Scientific literature, clinical-trial records, regulatory developments, corporate announcements and market research can generate more information than an individual analyst can efficiently review. The emergence of AI-enabled research tools is therefore changing expectations around how quickly evidence can be located, compared and interpreted.
Roots Analysis is responding to this shift through LabKairos (https://www.rootsanalysis.com/labkairos ), an AI-enabled market-intelligence platform built around its research library, and BioSignalIQ, a commercial-intelligence platform designed to connect life-sciences developments with account priorities, evidence and timing. The two platforms address different parts of the intelligence workflow while remaining connected to the organization's broader research capabilities.
AI Changes the Accessibility of Research
A conventional research library requires users to locate individual documents before extracting the information relevant to a particular question. An AI-enabled interface can change that process by allowing users to query a structured knowledge base directly.
Roots Analysis describes LabKairos as an AI market-intelligence platform powered by a decade-plus proprietary research library covering pharmaceutical, biotech and healthcare studies. The platform is designed to provide sourced answers, with claims linked to specific reports, editions and pages.
That source connection is particularly important for professional research. In pharmaceutical and biotech strategy, a market figure or analytical conclusion may need to be checked before being incorporated into a board presentation, investment thesis or commercial assessment.
LabKairos Combines AI With Source Traceability
LabKairos' distinguishing feature is therefore not simply conversational access to information. Roots Analysis( https://www.rootsanalysis.com/ ) states that the platform is grounded in proprietary research rather than the open web and that answers resolve to specific source material.
The platform also presents different use cases for analysts, investors and strategy teams, reflecting the fact that the same underlying research can answer different questions depending on the decision being considered.
This approach is particularly relevant to life-sciences research because the evidence base is heterogeneous. Market data, clinical development, technology assessment and regulatory information can require different levels of interpretation, making source traceability important when AI is used to accelerate discovery.
The challenge facing pharmaceutical and biotech intelligence teams is no longer simply finding information. Scientific literature, clinical-trial records, regulatory developments, corporate announcements and market research can generate more information than an individual analyst can efficiently review. The emergence of AI-enabled research tools is therefore changing expectations around how quickly evidence can be located, compared and interpreted.
Roots Analysis is responding to this shift through LabKairos (https://www.rootsanalysis.com/labkairos ), an AI-enabled market-intelligence platform built around its research library, and BioSignalIQ, a commercial-intelligence platform designed to connect life-sciences developments with account priorities, evidence and timing. The two platforms address different parts of the intelligence workflow while remaining connected to the organization's broader research capabilities.
AI Changes the Accessibility of Research
A conventional research library requires users to locate individual documents before extracting the information relevant to a particular question. An AI-enabled interface can change that process by allowing users to query a structured knowledge base directly.
Roots Analysis describes LabKairos as an AI market-intelligence platform powered by a decade-plus proprietary research library covering pharmaceutical, biotech and healthcare studies. The platform is designed to provide sourced answers, with claims linked to specific reports, editions and pages.
That source connection is particularly important for professional research. In pharmaceutical and biotech strategy, a market figure or analytical conclusion may need to be checked before being incorporated into a board presentation, investment thesis or commercial assessment.
LabKairos Combines AI With Source Traceability
LabKairos' distinguishing feature is therefore not simply conversational access to information. Roots Analysis( https://www.rootsanalysis.com/ ) states that the platform is grounded in proprietary research rather than the open web and that answers resolve to specific source material.
The platform also presents different use cases for analysts, investors and strategy teams, reflecting the fact that the same underlying research can answer different questions depending on the decision being considered.
This approach is particularly relevant to life-sciences research because the evidence base is heterogeneous. Market data, clinical development, technology assessment and regulatory information can require different levels of interpretation, making source traceability important when AI is used to accelerate discovery.
Roots Analysis and the New Era of AI-Enabled Market Intelligence
The challenge facing pharmaceutical and biotech intelligence teams is no longer simply finding information. Scientific literature, clinical-trial records, regulatory developments, corporate announcements and market research can generate more information than an individual analyst can efficiently review. The emergence of AI-enabled research tools is therefore changing expectations around how quickly evidence can be located, compared and interpreted.
Roots Analysis is responding to this shift through LabKairos (https://www.rootsanalysis.com/labkairos ), an AI-enabled market-intelligence platform built around its research library, and BioSignalIQ, a commercial-intelligence platform designed to connect life-sciences developments with account priorities, evidence and timing. The two platforms address different parts of the intelligence workflow while remaining connected to the organization's broader research capabilities.
AI Changes the Accessibility of Research
A conventional research library requires users to locate individual documents before extracting the information relevant to a particular question. An AI-enabled interface can change that process by allowing users to query a structured knowledge base directly.
Roots Analysis describes LabKairos as an AI market-intelligence platform powered by a decade-plus proprietary research library covering pharmaceutical, biotech and healthcare studies. The platform is designed to provide sourced answers, with claims linked to specific reports, editions and pages.
That source connection is particularly important for professional research. In pharmaceutical and biotech strategy, a market figure or analytical conclusion may need to be checked before being incorporated into a board presentation, investment thesis or commercial assessment.
LabKairos Combines AI With Source Traceability
LabKairos' distinguishing feature is therefore not simply conversational access to information. Roots Analysis( https://www.rootsanalysis.com/ ) states that the platform is grounded in proprietary research rather than the open web and that answers resolve to specific source material.
The platform also presents different use cases for analysts, investors and strategy teams, reflecting the fact that the same underlying research can answer different questions depending on the decision being considered.
This approach is particularly relevant to life-sciences research because the evidence base is heterogeneous. Market data, clinical development, technology assessment and regulatory information can require different levels of interpretation, making source traceability important when AI is used to accelerate discovery.
0 Comentários
0 compartilhamentos